Related Experiment Video

Updated: May 19, 2026

Candida albicans Biofilm Chip (CaBChip) for High-throughput Antifungal Drug Screening
08:05

Candida albicans Biofilm Chip (CaBChip) for High-throughput Antifungal Drug Screening

Published on: July 18, 2012

Cryptococcus laurentii biofilms: structure, development and antifungal drug resistance

K Ajesh1, K Sreejith

  • 1Department of Biotechnology and Microbiology, Kannur University, Kannur, 670 661 Kerala, India.

Mycopathologia
|September 1, 2012
PubMed

Insights

Cryptococcus laurentii biofilms are resistant to common antifungals. This study investigated biofilm formation and antifungal activity, revealing sessile cells are recalcitrant to treatment, necessitating new therapeutic strategies.

Area of Science:

  • Medical Mycology
  • Antimicrobial Resistance
  • Biofilm Research

Background:

  • Fungal infections, particularly those involving biofilms, pose a significant threat due to treatment recalcitrance and mortality.
  • Cryptococcus laurentii is an emerging pathogen causing infections in immunocompromised individuals, with diverse clinical presentations.

Purpose of the Study:

  • To investigate the factors influencing Cryptococcus laurentii biofilm formation.
  • To evaluate the efficacy of common antifungal agents against C. laurentii biofilms.
  • To characterize the extracellular polymeric substances (EPS) of C. laurentii biofilms.

Main Methods:

  • Biofilm formation was assessed using the XTT reduction assay under varying conditions (temperature, pH, surface preconditioning).
  • Scanning electron microscopy (SEM) visualized biofilm structure and cell colonization.
  • Antifungal susceptibility testing (amphotericin B, itraconazole, fluconazole) was performed on both free-living and sessile C. laurentii cells.
  • EPS isolation via ultrasonication, followed by Fourier transform infrared spectroscopy (FT-IR) and inductively coupled plasma optical emission spectroscopy (ICP-OES) for chemical and elemental analysis.

Main Results:

  • Environmental factors like temperature, pH, and surface preconditioning influence C. laurentii biofilm development.
  • SEM revealed dense cell colonization and extensive extracellular polymeric substances in biofilms.
  • Antifungal agents showed reduced efficacy against C. laurentii biofilms compared to free-living cells, with sessile cells exhibiting resistance.
  • EPS composition and elemental content were analyzed, providing insights into the biofilm matrix.

Conclusions:

  • Cryptococcus laurentii biofilms present a significant challenge due to their inherent resistance to standard antifungal therapies.
  • Understanding biofilm formation and matrix composition is crucial for developing effective treatment strategies against C. laurentii infections.

More Related Videos

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms06:50

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms

Published on: September 16, 2022

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

Related Concept Videos

Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...